TETYANA FURMANETS: Open Payments
NPI 1316447162 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,308 in 14 payments from 2 companies in 2025. Trend: 2023 $7,510 · 2024 $16,300 · 2025 $7,308
Speaker / faculty: $5,850Travel & lodging: $880Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $7,170 |
| SANOFI-AVENTIS U.S. LLC | 1 | $138 |
Products named: OJJAARA, REZUROCK.
Industry payments across PA — which companies pay providers there.
